Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Beersheba
Clinical trial register · Israel

Clinical Trials in Beersheba, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Israel and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2438 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2438
Studies in scope
all four open statuses
1243
Recruiting now
open to new participants
461
Lead sponsors
across recruiting studies
Top sites
Ramat Gan 67 Jerusalem 64 Tel Aviv 53 Haifa 52 Petah Tikva 45
Narrow the registerReset
Recruitment status
Phase
Site location
Ramat Gan67 Jerusalem64 Tel Aviv53 Haifa52 Petah Tikva45
All 21 locations
Target enrolment
to

Trials with a site in Beersheba

18 of 2438 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Israel
Start
Active, closed
AbbVie
Phase 3
573
Petah Tikva, Tsrifin, Ashdod, Beersheba, Ramat Gan, Tel Aviv, Haifa
2025-06-17
Active, closed
AbbVie
Phase 2
185
Kefar Sava, Beersheba, Tel Aviv, Jerusalem
2024-12-13
Recruiting
AbbVie
Phase 2
590
Holon, Beersheba, Tel Aviv, Haifa
2024-09-04
Active, closed
AbbVie
Phase 2
156
Tsrifin, Jerusalem, Beersheba, Ramat Gan, Tel Aviv, Petah Tikva
2024-03-23
Active, closed
AbbVie
Observational
785
Beer Ya'akov, Haifa, Beersheba, Tel Aviv, Petah Tikva
2022-08-15
Active, closed
AbbVie
Observational
141
Rehovot, Afula, Jerusalem, Safed, Ashkelon, Beersheba, Ramat Gan, Tel Aviv
2021-04-26
Active, closed
AbbVie
Phase 3
527
Tsrifin, Jerusalem, Ashkelon, Beersheba, Ramat Gan, Tel Aviv, Petah Tikva
2020-09-30
Active, closed
AbbVie
Observational
100
Kfar Saba, Tel Aviv, Afula, Jerusalem, Safed, Beersheba, Ramat Gan, Haifa
2019-08-08
Active, closed
AbbVie
Phase 2
270
Kfar Saba, Beersheba, Ramat Gan, Haifa, Petah Tikva
2018-10-10
Active, closed
AbbVie
Phase 3
1,242
Jerusalem, Beersheba, Ramat Gan, Haifa, Petah Tikva
2018-08-28
Active, closed
AbbVie
Phase 3
1,533
Beersheba, Ramat Gan, Tel Aviv, Afula, Petah Tikva
2018-08-09
Active, closed
AbbVie
Phase 3
1,336
Jerusalem, Beersheba, Holon, Ramat Gan, Tel Aviv, Haifa
2018-04-09
Active, closed
AbbVie
Phase 3
747
Rehovot, Tsrifin, Jerusalem, Ashkelon, Beersheba, Tel Aviv, Petah Tikva
2018-03-21
Active, closed
AbbVie
Phase 3
950
Jerusalem, Beersheba, Haifa
2017-01-31
Rows per page Showing 1–18 of 18
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Israeli investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-israel/city/beersheba

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Israel and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,438 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 18 of those studies with a site in Beersheba that also match the filters currently applied.

How many clinical trials are recruiting in Beersheba?

3 of the 18 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 15 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Beersheba), 18 studies
PhaseStudiesRecruitingShare
Phase 310155.6%
Phase 24122.2%
Observational3016.7%
Phase 1/2115.6%

Most active sponsors

Lead sponsors with the most studies (Beersheba)
Lead sponsorStudiesRecruiting
AbbVie183
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.